Terms: = Germ cell tumor AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
26 results:
1. Distinguishing IDH mutation status in gliomas using FTIR-atr spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.
Kino S; Kanamori M; Shimoda Y; Niizuma K; Endo H; Matsuura Y
BMC Cancer; 2024 Feb; 24(1):222. PubMed ID: 38365669
[TBL] [Abstract] [Full Text] [Related]
2. Enhancer-driven transcription of MCM8 by E2F4 promotes atr pathway activation and glioma stem cell characteristics.
Sun YM; Zhang YM; Shi HL; Yang S; Zhao YL; Liu HJ; Li C; Liu HL; Yang JP; Song J; Sun GZ; Yang JK
Hereditas; 2023 Jun; 160(1):29. PubMed ID: 37349788
[TBL] [Abstract] [Full Text] [Related]
3. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract] [Full Text] [Related]
4. tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
[TBL] [Abstract] [Full Text] [Related]
5. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
6. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
7. ATM germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
[TBL] [Abstract] [Full Text] [Related]
8. Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer.
Wang Q; Li Z; Yang J; Peng S; Zhou Q; Yao K; Cai W; Xie Z; Qin F; Li H; Chen X; Li K; Huang H
Cancer Biol Med; 2021 Oct; 19(8):1193-210. PubMed ID: 34591415
[TBL] [Abstract] [Full Text] [Related]
9. Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma.
Talele S; Zhang W; Burgenske DM; Kim M; Mohammad AS; Dragojevic S; Gupta SK; Bindra RS; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2021 Dec; 379(3):343-357. PubMed ID: 34556535
[TBL] [Abstract] [Full Text] [Related]
10. Economic burden for retinoblastoma patients in China.
Zhou Y; Cai S; Jin M; Jiang C; Xu N; Duan C; Peng X; Zhao J; Ma X
J Med Econ; 2020 Dec; 23(12):1553-1557. PubMed ID: 33000977
[TBL] [Abstract] [Full Text] [Related]
11. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract] [Full Text] [Related]
12. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma cell Death.
He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
[TBL] [Abstract] [Full Text] [Related]
13. Factors Associated With the Improved Survival of Head and Neck Neuroblastomas Compared to Other Body Sites.
Kaufmann MR; Camilon PR; Janz TA; Levi JR
Ann Otol Rhinol Laryngol; 2019 Mar; 128(3):241-248. PubMed ID: 30565471
[TBL] [Abstract] [Full Text] [Related]
14. MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines.
Aygun N; Altungoz O
Mol Med Rep; 2019 Jan; 19(1):345-361. PubMed ID: 30483774
[TBL] [Abstract] [Full Text] [Related]
15. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain tumors.
Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
[TBL] [Abstract] [Full Text] [Related]
17. Using Attenuated Total Reflection-Fourier Transform Infra-Red (atr-FTIR) spectroscopy to distinguish between melanoma cells with a different metastatic potential.
Minnes R; Nissinmann M; Maizels Y; Gerlitz G; Katzir A; Raichlin Y
Sci Rep; 2017 Jun; 7(1):4381. PubMed ID: 28663552
[TBL] [Abstract] [Full Text] [Related]
18. MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
Rinner B; Gandolfi G; Meditz K; Frisch MT; Wagner K; Ciarrocchi A; Torricelli F; Koivuniemi R; Niklander J; Liegl-Atzwanger B; Lohberger B; Heitzer E; Ghaffari-Tabrizi-Wizsy N; Zweytick D; Zalaudek I
Sci Rep; 2017 May; 7(1):2098. PubMed ID: 28522871
[TBL] [Abstract] [Full Text] [Related]
19. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of atr-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract] [Full Text] [Related]
20. Location of brain tumor intersecting white matter tracts predicts patient prognosis.
Mickevicius NJ; Carle AB; Bluemel T; Santarriaga S; Schloemer F; Shumate D; Connelly J; Schmainda KM; LaViolette PS
J Neurooncol; 2015 Nov; 125(2):393-400. PubMed ID: 26376654
[TBL] [Abstract] [Full Text] [Related]
[Next]
